Built by RNA drug developers, for the patients who are waiting.
Founded in 2025 and headquartered in Masdar City, Abu Dhabi, ValamAi brings together entrepreneurs and experts in RNA drug development and business building.
Scientific depth, operational discipline.
ValamAi is complemented by a strong scientific advisory board spanning research, clinical, technical and commercialization expertise.
Our people have led programs from early discovery through to regulatory approval at organizations including Roche, Novartis, Lonza and Takeda. Together, they bring the scientific depth and operational discipline needed to advance a novel RNA therapeutics platform toward the clinic.
We believe that great science combined with a collaborative, low-ego culture is what allows a small team to compete with much larger organizations — and to move faster for the patients who are waiting.
Meet the teamFounded
2025
Headquarters
Incubator Building, Masdar City, Abu Dhabi, UAE
Focus
First-in-class RNA therapeutics for unmet medical needs
Experience from
Roche · Novartis · Lonza · Takeda
What makes a small team move fast
Scientific depth
Experience leading programs from early discovery through to regulatory approval.
Operational discipline
The rigor needed to advance a novel RNA therapeutics platform toward the clinic.
Collaborative, low-ego culture
Great science and open teamwork let us compete with much larger organizations.